Qube Research & Technologies (QRT)
TARA icon

Qube Research & Technologies (QRT)’s Protara Therapeutics TARA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$922K Buy
177,004
+62,673
+55% +$371K ﹤0.01% 2533
2025
Q4 		$609K Buy
+114,331
New +$636K ﹤0.01% 2741
2025
Q2 		– Sell
-61,917
Closed -$264K – 3964
2025
Q1 		$264K Buy
+61,917
New +$277K ﹤0.01% 2778
2024
Q3 		– Sell
-2
Closed -$4 – 4090
2024
Q2 		$4 Hold
2
– – ﹤0.01% 3665
2024
Q1 		$8 Hold
2
– – ﹤0.01% 4309
2023
Q4 		$4 Hold
2
– – ﹤0.01% 4221
2023
Q3 		$3 Buy
+2
New +$5 ﹤0.01% 3997

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TARA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Protara Therapeutics (TARA) stake by 55% in Q1 2026, buying an estimated $371K and bringing the position to 177,004 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Qube Research & Technologies (QRT) first reported a position in TARA in Q3 2023 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 177,004 shares of Protara Therapeutics worth $922K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 62,673 Protara Therapeutics shares in Q1 2026, an estimated $371K.
  • Protara Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2533 holding.
  • Qube Research & Technologies (QRT) first reported a position in Protara Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.